Literature DB >> 2740065

Serum and tissue trace metal levels in lung cancer.

M Díez1, M Arroyo, F J Cerdàn, M Muñoz, M A Martin, J L Balibrea.   

Abstract

Copper, zinc, magnesium, calcium and iron were measured in serum and lung tissue - tumor mass and histologically nonneoplastic tissue - from lung cancer patients and compared with serum concentrations in healthy subjects and control lung tissue obtained from patients with nonmalignant lung disease. Lung cancer patients showed a significant increase in serum Cu and Cu/Zn ratio levels and decrease in serum Zn and Fe concentrations. These findings were correlated with TNM stage of the disease, but not with histologic type of tumor. Malignant lung tissue showed a higher level of Cu, Ca, Mg, and Cu/Zn ratio and lower Zn level than that found in control samples, as well as an increase in Cu, Mg and Cu/Zn ratio concentrations with regard to histologically nonneoplastic tissue samples from the same patient. Tissue concentration of trace metals was not significantly influenced either by histologic type of tumor or clinical TNM stage. Significant correlation coefficients between serum and tissue trace metal levels were not found.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2740065     DOI: 10.1159/000226722

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  42 in total

1.  A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cells.

Authors:  Fei Wang; Shumei Zhai; Xiaojun Liu; Liwen Li; Shirley Wu; Q Ping Dou; Bing Yan
Journal:  Cancer Lett       Date:  2010-10-29       Impact factor: 8.679

Review 2.  Novel metals and metal complexes as platforms for cancer therapy.

Authors:  Michael Frezza; Sarmad Hindo; Di Chen; Andrew Davenport; Sara Schmitt; Dajena Tomco; Q Ping Dou
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

Review 3.  New uses for old copper-binding drugs: converting the pro-angiogenic copper to a specific cancer cell death inducer.

Authors:  Di Chen; Q Ping Dou
Journal:  Expert Opin Ther Targets       Date:  2008-06       Impact factor: 6.902

4.  Synthesis of Dipyridyl Ketone Isonicotinoyl Hydrazone Copper(II) Complex: Structure, Anticancer Activity and Anticancer Mechanism.

Authors:  JunGang Deng; Wei Chen; Hang Deng
Journal:  J Fluoresc       Date:  2016-08-03       Impact factor: 2.217

5.  Positron emission tomography of human hepatocellular carcinoma xenografts in mice using copper (II)-64 chloride as a tracer with copper (II)-64 chloride.

Authors:  Haiyuan Zhang; Huawei Cai; Xin Lu; Otto Muzik; Fangyu Peng
Journal:  Acad Radiol       Date:  2011-12       Impact factor: 3.173

6.  Changes in blood concentrations of trace metals in cancer patients receiving cisplatin-based chemotherapy.

Authors:  Tsutomu Nakamura; Minoru Takahashi; Riho Niigata; Kazuhiko Yamashita; Manabu Kume; Midori Hirai; Hiroyuki Yasui
Journal:  Biomed Rep       Date:  2016-10-24

7.  Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing.

Authors:  Claire L Soave; Tracey Guerin; Jinbao Liu; Q Ping Dou
Journal:  Cancer Metastasis Rev       Date:  2017-12       Impact factor: 9.264

8.  Novel 8-hydroxylquinoline analogs induce copper-dependent proteasome inhibition and cell death in human breast cancer cells.

Authors:  Vesna Milacic; Peifu Jiao; Bin Zhang; Bing Yan; Q Ping Dou
Journal:  Int J Oncol       Date:  2009-12       Impact factor: 5.650

9.  Dietary magnesium and DNA repair capacity as risk factors for lung cancer.

Authors:  Somdat Mahabir; Qingyi Wei; Stephanie L Barrera; Yong Quan Dong; Carol J Etzel; Margaret R Spitz; Michele R Forman
Journal:  Carcinogenesis       Date:  2008-04-30       Impact factor: 4.944

10.  Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity.

Authors:  Vesna Milacic; Di Chen; Lorena Giovagnini; Alejandro Diez; Dolores Fregona; Q Ping Dou
Journal:  Toxicol Appl Pharmacol       Date:  2008-03-28       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.